Vaccination Fears: What the School Nurse Can Do

Barlow W. E. , Davis R. L. , Glasser J. W. , Rhodes P. H. , Thompson R. S. , Mullooly J. P. , Black S. B. , Shinefield H. R. , Ward J. I. , Marcy S. M. , De Stefano F. , Chen R. T. , Immanuel V. , Pearson IA. , Vadheim C. M. , Rebolledo V. , Christakis D. , Benson P. J. , & Lewis N. (2001). The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. New England Journal of Medicine, 345 (9), 656–661.

Centers for Disease Control Prevention (1991). Diphtheria, tetanus, and pertussis: Recommendations for vaccine use and other preventive measures: Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report, 40 (RR-10), 1–28.

Centers for Disease Control and Prevention (2000). CDC Fact Book 2000/2001. Retrieved June 17, 2002 from the World Wide Web: http://www.cdc.gov/maso/factbook/main.htm

Centers for Disease Control and Prevention (2002). Recommended childhood immunization schedule. United States, 2002. Retrieved June 17, 2002 from the World Wide Web: http://www.cdc.gov/nip/recs/child-schedule.pdf

Committee on Infectious Diseases. (2000). Varicella vaccine update (RE9941). Pediatrics, 705 (1), 136–141.

Dales L. , Hammer S. J. , & Smith N. J. (2001). Time trends in autism and in MMR immunization coverage in California. Journal of the American Medical Association, 285 (9), 1183–1185.

Elliman D. A. , & Bedford H. E. (2001). MMR vaccine-worries are not justified. Archives of Disease in Childhood, 85 (4), 271–274.

Gale J. L. , Thapa P. B. , Wassilak S. G. , Bobo J. K. , Mendelman P. M. , & Foy H. Ì. (1994). Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine: A population-based case-control study. Journal of the American Medical Association, 271 (1), 37–41.

Griffin M. R. , Ray W. A. , Mortimer E. A. , Fenichel G. M. , & Schaffner W. (1990). Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. Journal of the American Medical Association, 263 (12), 1641–1645.

Immunization Safety Review Committee on Health Promotion and Disease Prevention, Institute of Medicine (2001). immunization safety review: Measles-mumps-rubella vaccine and autism. Washington, D.C.: National Academy Press.

Jiles R. , Fuchs C. , & Klevens R. (2000). Vaccination Coverage Among Children Enrolled in Head Start Programs or Day Care Facilities or Entering School. Morbidity and Mortality Weekly Report, 49, 27–38.

Miller D. , Wadsworth J. , & Ross E. (1988). Severe neurological illness: further analyses of the British National Childhood Encephalopathy Study. The Tokai Journal of Experimental and Clinical Medicine, 13 (Suppl), 145–155.

National Center for Infectious Diseases (2001). Viral hepatitis A. Fact Sheet. Retrieved June 18, 2002 from the World Wide Web: http://www.cdc.gOv/ncidod/diseases/hepatitis/a/fact.htm

National Foundation for Infectious Diseases (2001). Facts About Influenza for Adults. Retrieved June 18, 2002 from the World Wide Web: http://www.nfid.org/factsheets/influadult.htm

National Immunization Program (2000). Sample Op-Ed Article. Chickenpox: It's more serious than you think. Retrieved June 18, 2002 from the World Wide Web: http://www.cdc.gov/nip/publications/niiw/pastPDF/SampleOpEdChickenpox.pdf

National Immunization Program (2001). Diptheria, Tetanus & Pertussis Vaccines. Vaccine Information Statement. DTa P (7/30/01). Retrieved June 18, 2002 from the World Wide Web: http://www.cdc.gov/nip/publications/VIS/vis-dtp.pdf

National Immunization Program (2001). Six common misconceptions about vaccination and how to respond to them. Retrieved March 12, 2002 from the World Wide Web: http://www.cdc.gov/nip/publications/6mishome.htm

National Immunization Program (2001). Vaccination coverage among children enrolled in Head Start Programs and licensed child care centers and entering school - United States and selected reporting areas, 1999-2000 school year. Morbidity and Mortality Weekly Report, 50, 847–855.

Taylor B. , Miller E. , Farrington C. P. , Petropoulos M. C. , Favot-Mayaud I. , Li J. , & Waight P. A. (1999). Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association. Lancet, 353 (9169), 2026–2029.

The National Partnership for Immunization (NPI) (2001). Reference guide on vaccines and vaccine safety. Retrieved June 17, 2002 from the World Wide Web: http://www.partnersforim-munization.org/guidebook.htm

US Department of Health and Human Services (2000). Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, D.C.: Government U.S. Printing Office.

US Food and Drug Administration (FDA) (2001). Thimerosal in Vaccines. Frequently Asked Questions. Retrieved June 18, 2002 from the World Wide Web: http://www.fda.gov/cber/vaccine/thimfaq.htm#q6

Wakefield A. J. , Murch S. H. , Anthony A. , Linnell J. , Casson D. M. , Malik M. , Berelowitz M. , Dhillon A. P. , Thomson M. A. , Harvey P. , Valentine A. , Davies S. E. , & Walker-Smith J. A. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 351 (9103), 637–641.

Walker A. M. , Jick H. , Perera D. R. , Knauss T. A. , & Thompson R. S. (1988). Neurologic events following diphtheria-tetanus-pertussis immunization. Pediatrics, 81 (3), 345–349.